BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRAF
,
glucose metabolic process
,
Influenza
,
Neuron
,
Nosology
,
Lovastatin
,
rs3825942
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
renal tumours
Summary
General Info
Curated Studies
Most Correlated Studies
Chromophobe renal cell carcinoma and renal oncocytoma gene expression profiling
Gene expression of different types of renal tumors
Clear cell renal cell carcinoma and normal adjacent tissue expression profiles
Renal carcinoma derived cell lines following 5-Aza-2-deoxycytidine (AZA) treatment
GSK cancer cell line transcript profiling
Explore Curated Studies Results
Literature
Most Relevant Literature
Papillary renal neoplasm with reverse polarity: a clinicopathological analysis].
Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse po…
Biomarkers for renal cell tumours].
Unclassified Oncocytic Renal Neoplasm with Rib and Liver Metastases: Metastatic Oncocytoma?
Do we need an updated classification of oncocytic renal tumors? : Emergence of low-grade oncocytic t…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
MRI in Renal Tumors
Irreversible Electroporation(IRE) For Unresectable Renal Tumors
Study of Cryotherapy for Renal Tumors
SABR for Renal Tumors
Multiparametric MRI for Diagnosing Small Renal Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ